Literature DB >> 24648947

True incidence of uterine adenomatoid tumors.

Hirofumi Nakayama1, Hideki Teramoto2, Mitsue Teramoto2.   

Abstract

Uterine adenomatoid tumors (UATs) are benign tumors of the uterine serosa and myometrium that originate from the mesothelium and forming gland-like structures. This study was conducted in order to determine the true incidence of UATs, which are usually an incidental finding during uterine surgery performed for other causes. UATs may resemble pre-existing vessels and lymphatic ducts, as well as metastatic adenocarcinomas. A total of 199 consecutive surgical operations (134 hysterectomies and 65 uterus-preserving tumor excisions) were performed by a single team of gynecologists and examined by a single attending pathologist, who performed a thorough macro- and microscopic examination of all the specimens. UATs were identified in nine (5%) out of the 199 cases [six (5%) out of the 134 hysterectomies and three (5%) out of the 65 uterus-preserving tumor excisions]. Therefore, the true incidence of UATs may be significantly higher than 1%, which is the incidence reported in the presently available literature.

Entities:  

Keywords:  incidence; uterine adenomatoid tumor

Year:  2013        PMID: 24648947      PMCID: PMC3917104          DOI: 10.3892/br.2013.72

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  1 in total

1.  Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases.

Authors:  Ankur R Sangoi; Jesse K McKenney; Erich J Schwartz; Robert V Rouse; Teri A Longacre
Journal:  Mod Pathol       Date:  2009-06-19       Impact factor: 7.842

  1 in total
  1 in total

1.  Diagnosis and Management of an Adenomatoid Uterine Tumor: Ultrasound, Magnetic Resonance Imaging, Surgical Appearance, and Pathology Correlation.

Authors:  Jennie Orlando; Cornelia deRiese; Eric Blackwell; Suzanne Graham; Jennifer Phy
Journal:  Biores Open Access       Date:  2018-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.